Monday, October 25, 2021
- Advertisement -spot_img



Bhutan PM congratulates Modi on ‘landmark’ Covid vaccination drive

Addressing the country digitally, the Prime Minister said that India managed to make two 'Made-in-India' vaccines in a very short period which usually takes years.

All you need to know about India’s 2 Covid vaccines

So far, the government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.

Covid-19 vaccination drive begins in Odisha

"I am happy and excited that I received the much-awaited vaccine. I am feeling well," said Biranchi Nayak, the sanitary worker.

India to begin world’s largest immunisation exercise on Saturday

The world's biggest vaccination drives comes almost a year after the first coronavirus case was detected in India, which then claimed over 1.5 lakh lives and infected one crore people.

Telangana braces for adverse effects of Covid vaccines

58 healthcare centres ready to provide emergency services to individuals with Adverse Events Following Immunisation across State

Dr Reddy’s gets DCGI nod for phase 3 trial for Sputnik V vaccine

The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India

Covid vaccine to be rolled out in Telangana on Jan 16

Modi to launch nationwide drive through video link; 4,000 TS health staff to get inoculated at 139 centres on Day 1

Vaccination drive to be taken up in 14 centres in erstwhile Karimnagar

A total of 14 centres have been identified for vaccination in Karimnagar, Jagitial, Peddapalli and Rajanna-Sircilla districts on the first day of vaccination process from Saturday

No Covid vaccine for pregnant women, minors

The list of AEFI for Covishield include injection site tenderness, injection site pain, headache fatigue, myalgia, malaise, pyrexia, chills and arthralgia nausea

Bharat Biotech ships out Covaxin to 11 cities

After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru

Air India carries Bharat Biotech Covid vaccine from Hyderabad to Delhi

"Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible"

Bharat Biotech inks pact with Precisa to supply Covaxin to Brazil

The supplies of Covaxin will be prioritised for public market through direct procurement by Brazil government while the supplies to private market would be based upon receipt of market authorisation from the country's regulator

Ensure vaccination is smooth: KCR

Suggests advance arrangements be made to provide medical treatment if one develops a reaction

Vaccination in India likely by Jan 12

New Delhi: The much-anticipated inoculation programme against Covid-19 in the country is expected to begin by January 12, said government sources. "In all likelihood, the...

‘Approval of Covaxin a milestone for Indian vaccinology’

The Drugs Controller General of India on Sunday gave the permission to Bharat Biotech's Covaxin for use in an emergency situation.

Bharat Biotech rejects criticism on ‘Covaxin’ approval

The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data

Covaxin emergency use authorisation approval a significant landmark: Dr Ella

While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. Covaxin has generated excellent safety data with robust immune responses

Bharat Biotech recruits 23k volunteers for COVID-19 vaccine trials

Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV).

India approves 2 Covid vaccines for emergency use

This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.

Expert panel recommends Bharat Biotech’s ‘Covaxin’ for emergency use

The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI)

Latest news

- Advertisement -spot_img
Telangana Today